
SI-BONE, Inc. – NASDAQ:SIBN
SI-BONE stock price today
SI-BONE stock price monthly change
SI-BONE stock price quarterly change
SI-BONE stock price yearly change
SI-BONE key metrics
Market Cap | 547.08M |
Enterprise value | 713.69M |
P/E | -11.35 |
EV/Sales | 6.70 |
EV/EBITDA | -12.21 |
Price/Sales | 6.53 |
Price/Book | 7.06 |
PEG ratio | 2.06 |
EPS | -1.09 |
Revenue | 144.04M |
EBITDA | -41.38M |
Income | -43.11M |
Revenue Q/Q | 15.77% |
Revenue Y/Y | 23.45% |
Profit margin | -57.57% |
Oper. margin | -56.02% |
Gross margin | 85.24% |
EBIT margin | -56.02% |
EBITDA margin | -28.73% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSI-BONE stock price history
SI-BONE stock forecast
SI-BONE financial statements
Jun 2023 | 33.30M | -11.20M | -33.65% |
---|---|---|---|
Sep 2023 | 34.01M | -10.02M | -29.46% |
Dec 2023 | 38.85M | -10.98M | -28.26% |
Mar 2024 | 37.86M | -10.90M | -28.8% |
Sep 2025 | 47.58M | -8.34M | -17.53% |
---|---|---|---|
Oct 2025 | 47.57M | -8.45M | -17.78% |
Dec 2025 | 54.16M | -6.27M | -11.59% |
Mar 2026 | 47.06M | -10.14M | -21.55% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 233825000 | 56.41M | 24.13% |
---|---|---|---|
Sep 2023 | 230878000 | 57.27M | 24.81% |
Dec 2023 | 230425000 | 61.05M | 26.49% |
Mar 2024 | 223713000 | 58.17M | 26% |
Jun 2023 | -3.59M | 2.28M | 89.12M |
---|---|---|---|
Sep 2023 | -2.07M | -54.87M | -237K |
Dec 2023 | -2.29M | -18.91M | 842K |
Mar 2024 | -7.57M | 6.34M | 105K |
SI-BONE alternative data
Aug 2023 | 357 |
---|---|
Sep 2023 | 357 |
Oct 2023 | 357 |
Nov 2023 | 357 |
Dec 2023 | 357 |
Jan 2024 | 357 |
Feb 2024 | 357 |
Mar 2024 | 344 |
Apr 2024 | 344 |
May 2024 | 344 |
Jun 2024 | 344 |
Jul 2024 | 344 |
SI-BONE other data
Period | Buy | Sel |
---|---|---|
Jan 2024 | 0 | 13306 |
Feb 2024 | 0 | 58240 |
Mar 2024 | 0 | 5830 |
Apr 2024 | 0 | 6652 |
May 2024 | 0 | 10374 |
Jun 2024 | 0 | 341 |
Jul 2024 | 0 | 7538 |
Aug 2024 | 0 | 20300 |
Sep 2024 | 0 | 1414 |
Oct 2024 | 0 | 7531 |
Nov 2024 | 0 | 20444 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | RECUPERO ANTHONY J officer: Presiden.. | Common Stock | 2,070 | $12.17 | $25,194 | ||
Sale | DUNN JEFFREY W director | Common Stock | 1,609 | $12.43 | $20,001 | ||
Sale | RECUPERO ANTHONY J officer: Presiden.. | Common Stock | 314 | $12.93 | $4,059 | ||
Sale | RECUPERO ANTHONY J officer: Presiden.. | Common Stock | 1,501 | $12.63 | $18,958 | ||
Sale | RECUPERO ANTHONY J officer: Presiden.. | Common Stock | 2,122 | $12.53 | $26,593 | ||
Sale | MAHESHWARI ANSHUL officer: Chief Financial Officer | Common Stock | 1,165 | $12.7 | $14,798 | ||
Sale | MAHESHWARI ANSHUL officer: Chief Financial Officer | Common Stock | 1,274 | $12.67 | $16,139 | ||
Sale | FRANCIS LAURA director, officer.. | Common Stock | 1,042 | $12.67 | $13,197 | ||
Sale | FRANCIS LAURA director, officer.. | Common Stock | 3,191 | $12.48 | $39,836 | ||
Sale | FRANCIS LAURA director, officer.. | Common Stock | 2,025 | $12.61 | $25,541 |
Patent |
---|
Application Filling date: 20 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 9 Feb 2022 Issue date: 11 Aug 2022 |
Grant Filling date: 14 Feb 2019 Issue date: 28 Jun 2022 |
Grant Utility: Integrated implant Filling date: 29 Jan 2019 Issue date: 24 May 2022 |
Application Filling date: 31 Jan 2022 Issue date: 19 May 2022 |
Application Filling date: 26 Jul 2021 Issue date: 21 Apr 2022 |
Grant Utility: Fenestrated implant Filling date: 27 Aug 2019 Issue date: 5 Apr 2022 |
Application Filling date: 18 Oct 2021 Issue date: 3 Feb 2022 |
Grant Filling date: 14 May 2020 Issue date: 1 Feb 2022 |
Grant Utility: Implant placement Filling date: 11 Dec 2017 Issue date: 19 Oct 2021 |
Quarter | Transcript |
---|---|
Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 1 May 2023 | Q1 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Laura A. Francis (1967) Chief Executive Officer & Director | $617,850 |
Mr. Anthony J. Recupero (1959) Pres of Commercial Operations | $588,580 |
-
What's the price of SI-BONE stock today?
One share of SI-BONE stock can currently be purchased for approximately $15.49.
-
When is SI-BONE's next earnings date?
Unfortunately, SI-BONE's (SIBN) next earnings date is currently unknown.
-
Does SI-BONE pay dividends?
No, SI-BONE does not pay dividends.
-
How much money does SI-BONE make?
SI-BONE has a market capitalization of 547.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 30.52% to 138.89M US dollars.
-
What is SI-BONE's stock symbol?
SI-BONE, Inc. is traded on the NASDAQ under the ticker symbol "SIBN".
-
What is SI-BONE's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of SI-BONE?
Shares of SI-BONE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are SI-BONE's key executives?
SI-BONE's management team includes the following people:
- Ms. Laura A. Francis Chief Executive Officer & Director(age: 58, pay: $617,850)
- Mr. Anthony J. Recupero Pres of Commercial Operations(age: 66, pay: $588,580)
-
How many employees does SI-BONE have?
As Jul 2024, SI-BONE employs 344 workers.
-
When SI-BONE went public?
SI-BONE, Inc. is publicly traded company for more then 6 years since IPO on 17 Oct 2018.
-
What is SI-BONE's official website?
The official website for SI-BONE is si-bone.com.
-
Where are SI-BONE's headquarters?
SI-BONE is headquartered at 471 El Camino Real, Santa Clara, CA.
-
How can i contact SI-BONE?
SI-BONE's mailing address is 471 El Camino Real, Santa Clara, CA and company can be reached via phone at +40 82070700.
SI-BONE company profile:

SI-BONE, Inc.
si-bone.comNASDAQ
344
Medical - Devices
Healthcare
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Santa Clara, CA 95050
CIK: 0001459839
ISIN: US8257041090
CUSIP: 825704109